HEALTH● LOWSep 23 · Sep 23, 2026, 5:50 PM
AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma
Seeking Alpha Tech · western europe
AstraZeneca has been granted an EU label expansion for its COPD therapy and for Trixeo in asthma. This indicates an expansion of approved uses for these pharmaceutical products within the European Union.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoEven after explosive diarrhea outbreak Trump’s FDA looks to ease food requirementsThe Independent WorldHEALTH3h agoPope Leo recovers after lung surgeryNBC NewsHEALTH3h agoThe health of Leo XIV: the Pope advances in his recovery, but uncertainty remains about his visit to South AmericaClarínHEALTH3h agoHealthcare workers protest in virtually every state over pay, shortages and staffingMexico News Daily